Judge denies Pfizer’s request to run 2 programs to subsidize patients for expensive heart drug
Judge denies Pfizer’s request to run 2 programs to subsidize [...]
Judge denies Pfizer’s request to run 2 programs to subsidize [...]
Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health [...]
Is the cancer immunotherapy market up for disruption as AstraZeneca, [...]
U.S. appeals court sides with Catalyst, calling FDA approval of [...]
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka [...]
Insider trading on 2 M&A deals made former Goldman Sachs [...]
Fujifilm completes construction of Netherlands production facility, enters validation stage [...]
Mirum gets iBAT inhibitor Livmarli across the FDA finish line [...]
Despite rough start, Biogen’s Aduhelm should find footing, analysts say. [...]
Samsung Biologics sees more than 10x growth in value of [...]